Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Strata Critical Medical (SRTA) Non-Current Deferred Tax Liability (2020 - 2025)

Strata Critical Medical (SRTA) has disclosed Non-Current Deferred Tax Liability for 6 consecutive years, with $6.7 million as the latest value for Q4 2025.

  • Quarterly Non-Current Deferred Tax Liability rose 52.52% to $6.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.7 million through Dec 2025, up 52.52% year-over-year, with the annual reading at $6.7 million for FY2025, 52.52% up from the prior year.
  • Non-Current Deferred Tax Liability for Q4 2025 was $6.7 million at Strata Critical Medical, up from $181000.0 in the prior quarter.
  • The five-year high for Non-Current Deferred Tax Liability was $8.7 million in Q4 2022, with the low at $144000.0 in Q1 2022.
  • Average Non-Current Deferred Tax Liability over 5 years is $2.1 million, with a median of $379500.0 recorded in 2024.
  • The sharpest move saw Non-Current Deferred Tax Liability surged 1091.67% in 2023, then crashed 79.2% in 2024.
  • Over 5 years, Non-Current Deferred Tax Liability stood at $3.0 million in 2021, then soared by 185.09% to $8.7 million in 2022, then dropped by 5.11% to $8.2 million in 2023, then plummeted by 46.69% to $4.4 million in 2024, then soared by 52.52% to $6.7 million in 2025.
  • According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods came in at $6.7 million, $181000.0, and $210000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.